Balyasny Asset Management
ARTC

Balyasny Asset Management’s ARTHROCARE CORP ARTC Stock Holding History

Balyasny Asset Management’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-34,262
Closed -$1.38M – 770
2013
Q4 		$1.38M Buy
+34,262
New +$1.27M 0.02% 425
2013
Q3 		– Sell
-24,562
Closed -$848K – 819
2013
Q2 		$848K Buy
+24,562
New +$845K 0.01% 503

Other funds holding ARTC

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Balyasny Asset Management's ARTC Position: Q1 2014 in Review

Balyasny Asset Management sold out of ARTHROCARE CORP (ARTC) in Q1 2014, closing a stake of 34,262 shares — an estimated $1.38M sold.

Balyasny Asset Management first reported a position in ARTC in Q2 2013 and held it in 2 quarters. The position peaked at $1.38M in Q4 2013. 117 funds tracked by Wall St. Rank hold ARTC as of Q1 2014.

  • Balyasny Asset Management reported no remaining ARTHROCARE CORP position as of Q1 2014 after selling out during the quarter.
  • Balyasny Asset Management sold 34,262 ARTHROCARE CORP shares in Q1 2014, an estimated $1.38M.
  • Balyasny Asset Management first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 2 quarters.
  • Balyasny Asset Management's ARTHROCARE CORP position peaked at $1.38M in Q4 2013.
  • 117 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q1 2014.

Based on Balyasny Asset Management's 13F filing for Q1 2014, filed 15 May 2014.